AFOIX
Price
$18.08
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
PMAQX
Price
$47.96
Change
-$0.50 (-1.03%)
Updated
Nov 14 closing price
Ad is loading...

AFOIX vs PMAQX

Header iconAFOIX vs PMAQX Comparison
Open Charts AFOIX vs PMAQXBanner chart's image
Alger Mid Cap Focus I
Price$18.08
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Principal MidCap R6
Price$47.96
Change-$0.50 (-1.03%)
VolumeN/A
CapitalizationN/A
AFOIX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AFOIX vs. PMAQX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFOIX is a StrongBuy and PMAQX is a Buy.

FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 30B vs. AFOIX (304M). PMAQX pays higher dividends than AFOIX: PMAQX (0.10) vs AFOIX (0.00). AFOIX was incepted earlier than PMAQX: AFOIX (5 years) vs PMAQX (8 years). AFOIX is a more actively managed with annual turnover of: 121.07 vs. PMAQX (10.10). AFOIX (0) and PMAQX (0) have matching initial minimum investment requirements. AFOIX annual gain was more profitable for investors over the last year : 44.18 vs. PMAQX (32.12). AFOIX return over 5 years is better than : 78.78 vs. PMAQX (55.10).
AFOIXPMAQXAFOIX / PMAQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years8 years-
Gain YTD32.86526.395125%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets304M30B1%
Annual Yield % from dividends0.000.10-
Returns for 1 year44.1832.12138%
Returns for 3 years-24.016.88-349%
Returns for 5 years78.7855.10143%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIXT1.65-0.03
-1.79%
Lixte Biotechnology Holdings
ATRO16.49-0.38
-2.25%
Astronics Corp
LFST7.22-0.18
-2.43%
LifeStance Health Group
CVNA239.98-6.77
-2.74%
Carvana Co
IPSC1.33-0.08
-5.67%
Century Therapeutics